Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team

occupation: researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 6

Date

Title

Authors

2019-03-01

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

emmanuel ndashimye, Cissy Kityo, Peter Mugyenyi, Ann Sarah Walker, Andrew Kambugu, Jennifer A Thompson, Jose R. Arribas, Anne Hoppe, Joep J van Oosterhout, Nicholas Iain Paton, Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
2017-06-01

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa

emmanuel ndashimye, Ivan Mambule, Cissy Kityo, Peter Mugyenyi, Immaculate Nankya, Ann Sarah Walker, Kara K. Wools-Kaloustian, Jennifer A Thompson, Anne Hoppe, Joep J van Oosterhout, Philippa Easterbrook, Nicholas Iain Paton, Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team, Colin Warambwa, Silvia Bertagnolio
2017-05-08

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Cissy Kityo, Peter Mugyenyi, Immaculate Nankya, Ann Sarah Walker, emmanuel ndashimye, Jennifer A Thompson, Andrew Kambugu, Anne Hoppe, Joep J van Oosterhout, Philippa Easterbrook, Nicholas Iain Paton, Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team, Silvia Bertagnolio, Mary Kiconco
2017-11-03

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.

Margaret Thomason, Cissy Kityo, Peter Mugyenyi, Ann Sarah Walker, emmanuel ndashimye, Jennifer A Thompson, Andrew Kambugu, George Abongomera, Abraham Siika, Abbas Lugemwa, Anne Hoppe, Joep J van Oosterhout, Raymond Mwebaze, Aggrey Mweemba, Philippa Easterbrook, Nicholas Iain Paton, Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
2015-08-25

Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial

Alejandro Arenas-Pinto, Margaret Thomason, Ann Sarah Walker, Andrew Kambugu, Jennifer A Thompson, Abbas Lugemwa, Godfrey Musoro, Aggrey Mweemba, Nicholas Iain Paton, Hellen Musana, Dickens Atwongyeire, Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
2014-07-01

Assessment of second-line antiretroviral regimens for HIV therapy in Africa

Jose R. Arribas, Ivan Mambule, Cissy Kityo, Peter Mugyenyi, Ann Sarah Walker, Andrew Kambugu, Jennifer A Thompson, George Abongomera, Abraham Siika, Abbas Lugemwa, Anne Hoppe, Joep J van Oosterhout, Raymond Mwebaze, Aggrey Mweemba, Philippa Easterbrook, Nicholas Iain Paton, Ennie Chidziva, Dinah Tumukunde, Mary Kiconco, Dickens Atwongyeire, Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team

Human - wd:Q114437780

Welcome to Inventaire

the library of your friends and communities

learn more